Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Acadia Realty Trust
AKR
$2.86B
| $1.89M | ﹤0.01% |
53,700
+5,000
| +10% | +$166K |
|
2252
ClearOne Inc
CLRO
$14M
| $1.88M | ﹤0.01% |
10,820
-374
| -3% | -$66.6K |
|
|
FLY
2253
DELISTED
Fly Leasing Limited
FLY
| $1.88M | ﹤0.01% |
148,034
+65,588
| +80% | +$808K |
|
|
CXDC
2254
DELISTED
China XD Plastics Company Limited
CXDC
| $1.88M | ﹤0.01% |
583,500
+1,400
| +0.2% | +$4.49K |
|
|
ACAT
2255
DELISTED
Arctic Cat Inc
ACAT
| $1.88M | ﹤0.01% |
111,796
-8,530
| -7% | -$129K |
|
2256
FMC
FMC
$1.27B
| $1.88M | ﹤0.01% |
53,615
-111,841
| -68% | -$3.63M |
|
|
YDKG
2257
Yueda Digital Holding
YDKG
$5.92M
| $1.88M | ﹤0.01% |
167
-276
| -62% | -$3.02M |
|
|
GURE
2258
Gulf Resources
GURE
$4.63M
| $1.87M | ﹤0.01% |
23,276
+744
| +3% | +$60.2K |
|
|
VSI
2259
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.87M | ﹤0.01% |
60,400
-110,700
| -65% | -$3.33M |
|
2260
Shore Bancshares
SHBI
$800M
| $1.86M | ﹤0.01% |
155,700
+41,778
| +37% | +$474K |
|
2261
First Internet Bancorp
INBK
$254M
| $1.86M | ﹤0.01% |
79,700
+19,200
| +32% | +$483K |
|
2262
Crawford & Co Class B
CRD.B
$593M
| $1.86M | ﹤0.01% |
287,000
+12,900
| +5% | +$64K |
|
2263
Alto Ingredients
ALTO
$324M
| $1.86M | ﹤0.01% |
397,200
-499,182
| -56% | -$1.96M |
|
|
EGL
2264
DELISTED
Engility Holdings, Inc.
EGL
| $1.86M | ﹤0.01% |
99,100
-35,000
| -26% | -$629K |
|
|
RLOC
2265
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
| $1.85M | ﹤0.01% |
1,033,800
+18,000
| +2% | +$31.1K |
|
2266
EnerSys
ENS
$7.42B
| $1.85M | ﹤0.01% |
+33,200
| New | +$1.71M |
|
2267
Hurco Companies Inc
HURC
$146M
| $1.85M | ﹤0.01% |
56,082
-4,319
| -7% | -$118K |
|
|
EBIX
2268
DELISTED
Ebix Inc
EBIX
| $1.85M | ﹤0.01% |
45,280
+9,377
| +26% | +$327K |
|
|
CMD
2269
DELISTED
Cantel Medical Corporation
CMD
| $1.84M | ﹤0.01% |
25,825
-5,644
| -18% | -$354K |
|
2270
TechTarget
TTGT
$278M
| $1.84M | ﹤0.01% |
248,000
+49,100
| +25% | +$365K |
|
|
EXAC
2271
DELISTED
Exactech Inc
EXAC
| $1.84M | ﹤0.01% |
90,800
+11,400
| +14% | +$214K |
|
2272
Immersion
IMMR
$249M
| $1.84M | ﹤0.01% |
222,513
+98,100
| +79% | +$811K |
|
2273
RF Industries
RFIL
$148M
| $1.83M | ﹤0.01% |
679,100
-4,500
| -0.7% | -$17.7K |
|
|
NSM
2274
DELISTED
Nationstar Mortgage Holdings
NSM
| $1.83M | ﹤0.01% |
185,000
-363,800
| -66% | -$3.88M |
|
|
FGH
2275
DELISTED
FG Group Holdings Inc.
FGH
| $1.83M | ﹤0.01% |
398,900
+46,600
| +13% | +$204K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.